Efficient. Innovative. Reliable.

Our adjudicators comprise the largest HRS board-certified faculty of electrophysiologists across the globe, and we have enrolled more patients in heart rhythm-related trials than any other academic medical center. Our thought leadership, experience, and collaboration with the other trial support units at the DCRI set us apart.

DCRI’s ACL is an integral part of the DCRI Clinical Events Classification (CEC) group. The CEC group is committed to providing the highest-quality adjudicated endpoint data with scientific rigor, efficiency, and innovation by coordinating and conducting systematic, comprehensive, unbiased, blinded, and independent clinical events adjudication. With more than 170,000 projects adjudicated, more than 100 trials completed, more than 50 trials ongoing, and more than 32,000 reviews per year, CEC brings discipline to every project—from start to finish.

Our Approach

Our Services

The Future for Core Labs

Our Capabilities and Expertise

The ACL provides heart rhythm evaluation and adjudication across several modalities and multiple study designs and settings. Our services include:

Evaluation and adjudication of 12-lead electrocardiograms

Evaluation and adjudication of ambulatory monitoring tracings and results

Evaluation and adjudication of device-based diagnostics and electrograms (including but not limited to pacemaker, implantable cardioverter defibrillator, and cardiac resynchronization therapy recordings)

Our History

The DCRI and Duke ACL have participated in numerous studies of heart rhythm therapies over the past 15–20 years. Notable projects include the Mode Selection Trial in Sinus Node Dysfunction (MOST) and the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). The ACL also served as the core laboratory for the first study of noninvasive ventilation in patients with heart failure and sleep apnea (CAT-HF) and the first pharmacogenetic-guided trial of beta-blocker therapy for the prevention of recurrent AF in patients with heart failure (GENETIC AF).

Leadership

Sean D. Pokorney, MD, MBA

Sean is the director of the Arrhythmia Core Laboratory. He is a clinical cardiac electrophysiologist and assistant professor of medicine at Duke University Medical Center and the Duke Clinical Research Institute. Dr. Pokorney has published extensive research in heart rhythm medicine in several several notable publications including JAMA, Lancet, Circulation, Journal of the American College of Cardiology, Heart Rhythm, JACC Electrophysiology, and Circulation Arrhythmia and Electrophysiology.Contact: sean.pokorney@duke.edu

Lauren Arney, RN

Lauren is the project leader for the Duke Arrhythmia Core Laboratory. She is an experienced project leader with over 11 years of combined expertise. Her knowledge extends to clinical trial management, clinical event committee classification processing and project management for global clinical trials, electronic adjudication module database development, staff management and mentorship, and clinical nursing. Her current focus is in clinical events classification and core lab project management. Lauren is a registered nurse. Contact: lauren.arney@duke.edu.

WordPress is a content management system and should not be used to upload any PHI as it is not an environment for which we exercise oversight, meaning you the author are responsible for the content you post. Please use this system accordingly.